Related Experiment Video
Updated: Jun 26, 2026

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide
Published on: January 30, 2026
Respiratory function during infancy in survivors of the INNOVO trial
Ah-Fong Hoo1, Caroline S Beardsmore, Rosemary A Castle
1Portex Anaesthesia, Intensive Therapy and Respiratory Medicine Unit, UCL Institute of Child Health, London, UK. a.hoo@ich.ucl.ac.uk
Insights
Inhaled nitric oxide (iNO) did not improve long-term lung function in infants with severe respiratory failure. Airway function remained reduced at one year, regardless of iNO treatment, indicating persistent effects of neonatal respiratory distress.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Respiratory Physiology
Background:
- Inhaled nitric oxide (iNO) has shown short-term benefits for hypoxemic infants, improving oxygenation and reducing ECMO needs.
- However, the long-term impact of iNO on infant lung function following severe respiratory failure remains unclear.
Purpose of the Study:
- To compare lung function at approximately one year of age in infants with severe respiratory failure, with and without iNO treatment.
- To compare these outcomes to the lung function of healthy infants.
Main Methods:
- Maximal expiratory flow at functional residual capacity (V'maxFRC) was measured in survivors of the INNOVO trial at ~1 year of age.
- Results were expressed as Z-scores, adjusted for sex and body size, using data from healthy controls.
Main Results:
- Reduced V'maxFRC Z-scores were observed in infants with prior respiratory failure, irrespective of iNO allocation (mean Z-scores: -2.0 for iNO, -2.6 for no iNO).
- No significant difference in lung function was found between the iNO and no iNO groups.
- Significant respiratory morbidity occurred in both groups during the first year of life.
Conclusions:
- Severe respiratory failure at birth is associated with reduced airway function at one year of age.
- The administration of iNO does not appear to alter this long-term outcome.
Rationale:
Despite encouraging reports suggesting that inhaled nitric oxide (iNO) appear to improve outcome in hypoxemic term and near term infants by improving oxygenation and reducing need for ECMO, the long-term benefits of iNO remain unclear. This study aimed to compare lung function at approximately 1 year in infants who were and were not randomly allocated to iNO as part of their neonatal management for severe respiratory failure at birth. Furthermore, results were compared to lung function of healthy infants.
Methods:
Maximal expiratory flow at functional residual capacity (V'maxFRC) was measured at approximately 1 year of age (corrected for any prematurity) in survivors of the INNOVO trial. Results were expressed as Z-scores, adjusted for sex and body size, based on data from healthy controls using identical techniques.
Results:
Technically satisfactory results were obtained in 30 infants (53% < 34 weeks gestation), 19 of whom were randomized to receive iNO V'maxFRC. Z-score was significantly reduced in infants with prior respiratory failure, whether or not they had been allocated to iNO (mean (SD) Z-score: -2.0 (1.2) and -2.6 (1.1), respectively, 95% CI difference; iNO vs. no iNO: -0.3; 1.6, P = 0.2). There was significant respiratory morbidity in both groups during the first year of life.
Conclusions:
These results suggest that airway function remains reduced at 1 year of age following severe respiratory failure at birth, whether or not iNO is administered.
Related Concept Videos
Respiratory Capacities
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
Respiratory Volumes and Capacities I
Respiratory Syncytial Virus Disease
Respiratory Volumes
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
Respiratory Volumes and Capacities
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: